4.7 Review

Highlights of the 12th International Bordetella Symposium

Journal

CLINICAL INFECTIOUS DISEASES
Volume 71, Issue 9, Pages 2521-2526

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa651

Keywords

Bordetella; whooping cough; pertussis epidemiology; pertussis vaccines; Bordetella genomics

Funding

  1. Universite Libre de Bruxelles
  2. Universite de Lille
  3. National Institute of Allergy and Infectious Diseases [1 R13AI 145245-01]
  4. US Food and Drug Administration [1R13FD006613-01]
  5. ILiAD Biotechnologies
  6. GlaxoSmithKline
  7. BioNet
  8. Microbiology Society
  9. Sanofi Pasteur

Ask authors/readers for more resources

To commemorate the 100th anniversary of the Nobel prize being awarded to Jules Bordet, the discoverer of Bordetella pertussis, the 12th International Bordetella Symposium was held from 9 to 12 April 2019 at the Universite Libre de Bruxelles, where Jules Bordet studied and was Professor of Microbiology. The symposium attracted more than 300 Bordetella experts from 34 countries. They discussed the latest epidemiologic data and clinical aspects of pertussis, Bordetella biology and pathogenesis, immunology and vaccine development, and genomics and evolution. Advanced technological and methodological tools provided novel insights into the genomic diversity of Bordetella and a better understanding of pertussis disease and vaccine performance. New molecular approaches revealed previously unrecognized complexity of virulence gene regulation. Innovative insights into the immune responses to infection by Bordetella resulted in the development of new vaccine candidates. Such discoveries will aid in the design of more effective approaches to control pertussis and other Bordetella-related diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available